Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Wo2010029082a1 example 15 alpelisib google patents?

See the DrugPatentWatch profile for alpelisib

What is WO2010029082A1 Example 15 (and what does it have to do with alpelisib)?

WO2010029082A1 is a patent publication that includes specific worked examples. “Example 15” is one of those numbered embodiments, and it may mention particular chemical structures, intermediates, or experimental results tied to compounds in the disclosure. However, the exact text of “Example 15” (and whether it specifically names alpelisib) isn’t provided in your prompt, so I can’t reliably quote or describe what Example 15 contains.

If you want, paste the “Example 15” text from Google Patents (or a screenshot), and I can point out exactly where alpelisib appears (if it does), what the example is synthesizing or testing, and how it connects to alpelisib’s structure or activity claims.

How to find “Example 15” on Google Patents for WO2010029082A1

On Google Patents, you can usually locate the example text by:
- Opening the WO2010029082A1 page
- Using the page search within the document for “Example 15”
- Scanning the paragraph(s) under that heading for named compounds, reaction schemes, compounds numbered in the example, and any references to specific inhibitors

If you share the Google Patents link or the company/assignee shown on the page, I can also help interpret what the example is doing (for example, whether it’s a synthesis example versus a biological assay example).

Does “Example 15” in this patent correspond to alpelisib specifically?

Patents sometimes include many example compounds that are close analogs of known drugs, or they may include “representative” examples rather than the named marketed molecule. So the key question is whether:
- alpelisib is explicitly named in Example 15, or
- Example 15 gives a compound number/structure that matches alpelisib, or
- Example 15 is about an intermediate or method that can be used to make alpelisib

Without the Example 15 content, any match would be speculative.

If you want, I can map Example 15 to alpelisib’s structure

If you paste either:
- the compound description from Example 15 (IUPAC name, SMILES, formula, or structure description), or
- the experimental section results (IC50/assay target) if present,
I can help you determine whether it matches alpelisib or a related PI3K inhibitor and explain the relationship.

Quick check: what to send me

To answer precisely, send one of the following:
- The “Example 15” text from Google Patents
- The Google Patents URL for WO2010029082A1 Example 15
- The chemical name/structure in Example 15 that you believe is alpelisib

Once you provide that, I’ll extract the relevant part and explain how it connects to alpelisib.



Other Questions About Alpelisib :

Novartis ag 2009 alpelisib patent application? Novartis alpelisib 2009 patent synthesis? Novartis alpelisib synthesis 2009 patent? Wo 2010 029082 alpelisib patent? Wo 2009 novartis alpelisib patent? Alpelisib patent novartis 2009 synthesis? Wo 2010 029082 novartis alpelisib?